| Title |
Tailored P2Y12 inhibitor treatment in patients undergoing non-urgent PCI—the POPular Risk Score study
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, June 2019
|
| DOI | 10.1007/s00228-019-02696-z |
| Pubmed ID | |
| Authors |
Paul W. A. Janssen, Thomas O. Bergmeijer, Gert-Jan A. Vos, Johannes C. Kelder, Khalid Qaderdan, Thea C. Godschalk, Nicoline J. Breet, Vera H. M. Deneer, Christian M. Hackeng, Jurriën M. ten Berg |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 25 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 5 | 20% |
| Student > Master | 4 | 16% |
| Researcher | 3 | 12% |
| Student > Ph. D. Student | 3 | 12% |
| Student > Doctoral Student | 2 | 8% |
| Other | 2 | 8% |
| Unknown | 6 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 60% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 8% |
| Business, Management and Accounting | 1 | 4% |
| Nursing and Health Professions | 1 | 4% |
| Unknown | 6 | 24% |